Compound 4-methyl-N-[3-(4-methyl-1H-pyridine-1-IL) -5-(trifluoromethyl) phenyl]-3-[(4-pyridine-3-Ilpirimidin-2-IL) amino) aniline (Nilotinib) is used to treat diffusive disorders or other conditions mediated by Quinasa BCR-ABL, C-Kit, DDR1, DDR2 or PDGF-R, orally managing dispersion. Comments more than a month ago
Method for treating a proliferative disorder or other Pathological conditions mediated by the activity of kinase of bcr abl, c-kit, DDR1,DDR2 or PDGF - R which comprises oral administration of a compound derived from pirimidil - amino benzamide； and kit comprising the compound derived from pirimidil - amino benzamide.<；p>；Mé；todo para el tratamiento de un trastorno proliferativo u otras condiciones patoló；gicas mediadas por la actividad de cinasa de BCR-ABL, C-kit, DDR1, DDR2 o PDGF-R que comprende la administració；n oral de un compuesto derivado de pirimidil-amino-benzamida； y kit que comprende al compuesto derivado de pirimidil-amino-benzamida.<；/p>；
